VolitionRX Ltd
VNRX0.246USD
-0.001-0.40%
종가 02/06, 16:00（ET）시세는 15분 지연됩니다
26.97M시가총액
손실P/E TTM
자세한 내용은 VolitionRX Ltd 회사
VolitionRx Limited is a multi-national company focused on advancing the science of epigenetics. The Company is dedicated to saving lives and improving outcomes for people and animals with life-altering diseases through earlier detection, as well as disease and treatment monitoring. Through its subsidiaries, it is developing and commercializing blood tests to help diagnose and monitor a range of diseases, including cancers and diseases associated with NETosis, such as sepsis. Its key pillars are Nu.Q Vet, Nu.Q NETs, Nu.Q Discover, Nu.Q Cancer, and Capture-PCR. The Nu.Q Vet Cancer Test is commercially available as a cancer screening test in dogs. Nu.Q NETs is monitoring the immune system to save lives. Nu.Q Discover is a complete solution to profiling nucleosomes. Nu.Q Cancer monitoring disease progression, response to treatment and minimal residual disease. Capture-PCRTM is isolating and capturing circulating tumor-derived DNA from plasma samples for early cancer detection.
VolitionRX Ltd 정보
종목 코드 VNRX
회사 이름VolitionRX Ltd
상장일Feb 06, 2015
CEOButera (Salvatore Thomas)
직원 수85
유형Ordinary Share
회계 연도 종료Feb 06
주소1489 West Warm Springs Road
도시HENDERSON
증권 거래소NASDAQ OMX – NASDAQ Basic Amex
국가United States of America
우편 번호89014
전화17024251561
웹사이트https://volition.com/
종목 코드 VNRX
상장일Feb 06, 2015
CEOButera (Salvatore Thomas)
VolitionRX Ltd의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Mr. Guy Archibald Innes
Mr. Guy Archibald Innes
Independent Director
Independent Director
2.99M
+12000.00%
Mr. Cameron John Reynolds
Mr. Cameron John Reynolds
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
2.38M
+74700.00%
Dr. Jacob Vincent Micallef
Dr. Jacob Vincent Micallef
Chief Scientific Officer
Chief Scientific Officer
480.16K
+35400.00%
Mr. Terig Hughes
Mr. Terig Hughes
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
437.35K
+49200.00%
Dr. Salvatore Thomas Butera
Dr. Salvatore Thomas Butera
Chief Executive Officer of Volition Vet
Chief Executive Officer of Volition Vet
378.80K
+53400.00%
Dr. Jasmine Kway
Dr. Jasmine Kway
Chief Executive Officer of Singapore Volition
Chief Executive Officer of Singapore Volition
245.61K
+42000.00%
Dr. Alan Colman, Ph.D.
Dr. Alan Colman, Ph.D.
Independent Director
Independent Director
215.55K
+12000.00%
Mr. Gael Forterre
Mr. Gael Forterre
Chief Commercial Officer
Chief Commercial Officer
189.87K
-2010.00%
Mr. Nicholas Plummer
Mr. Nicholas Plummer
Group General Counsel
Group General Counsel
189.64K
-5647.00%
Mr. Rodney Gerard Rootsaert
Mr. Rodney Gerard Rootsaert
Corporate Secretary
Corporate Secretary
162.26K
-3196.00%
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. Guy Archibald Innes
Mr. Guy Archibald Innes
Independent Director
Independent Director
2.99M
+12000.00%
Mr. Cameron John Reynolds
Mr. Cameron John Reynolds
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
2.38M
+74700.00%
Dr. Jacob Vincent Micallef
Dr. Jacob Vincent Micallef
Chief Scientific Officer
Chief Scientific Officer
480.16K
+35400.00%
Mr. Terig Hughes
Mr. Terig Hughes
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
437.35K
+49200.00%
Dr. Salvatore Thomas Butera
Dr. Salvatore Thomas Butera
Chief Executive Officer of Volition Vet
Chief Executive Officer of Volition Vet
378.80K
+53400.00%
Dr. Jasmine Kway
Dr. Jasmine Kway
Chief Executive Officer of Singapore Volition
Chief Executive Officer of Singapore Volition
245.61K
+42000.00%
수익 분석
기업이 아직 관련 데이터를 공개하지 않았습니다.
기업이 아직 관련 데이터를 공개하지 않았습니다.
사업별
지역별
기업이 아직 관련 데이터를 공개하지 않았습니다.
주식 보유 통계
마지막 업데이트: Thu, Feb 5
마지막 업데이트: Thu, Feb 5
주주
주주 유형
주주
주주
비율
Lagoda Investment Management, L.P.
10.17%
Cotterford Co., Ltd.
9.78%
Armistice Capital LLC
7.64%
Innes (Guy Archibald)
2.44%
Reynolds (Cameron John)
1.94%
기타
68.04%
주주
주주
비율
Lagoda Investment Management, L.P.
10.17%
Cotterford Co., Ltd.
9.78%
Armistice Capital LLC
7.64%
Innes (Guy Archibald)
2.44%
Reynolds (Cameron John)
1.94%
기타
68.04%
주주 유형
주주
비율
Investment Advisor
12.09%
Corporation
10.60%
Hedge Fund
8.00%
Individual Investor
7.00%
Investment Advisor/Hedge Fund
1.12%
Research Firm
0.04%
Venture Capital
0.03%
기타
61.13%
기관 주식 보유
마지막 업데이트: Thu, Jan 1
마지막 업데이트: Thu, Jan 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q4
58
26.12M
21.27%
+1.98M
2025Q3
57
23.92M
20.70%
+1.72M
2025Q2
78
41.39M
40.30%
+860.69K
2025Q1
83
44.42M
46.85%
+2.70M
2024Q4
82
41.53M
44.82%
+1.50M
2024Q3
82
38.59M
41.90%
+9.42M
2024Q2
82
28.77M
32.86%
+105.49K
2024Q1
84
28.22M
34.52%
+1.47M
2023Q4
87
26.17M
37.10%
+183.39K
2023Q3
91
25.37M
36.48%
-477.38K
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
Lagoda Investment Management, L.P.
12.49M
10.17%
+782.00K
+6.68%
Sep 30, 2025
Cotterford Co., Ltd.
12.01M
9.78%
--
--
Apr 25, 2025
Armistice Capital LLC
9.38M
7.64%
+887.35K
+10.45%
Sep 30, 2025
Innes (Guy Archibald)
2.98M
2.43%
+96.15K
+3.33%
Oct 14, 2025
Reynolds (Cameron John)
2.31M
1.88%
+20.00K
+0.87%
Nov 17, 2025
The Vanguard Group, Inc.
1.53M
1.25%
-94.68K
-5.83%
Sep 30, 2025
Concord International Inc.
1.01M
0.82%
--
--
Apr 25, 2025
Geode Capital Management, L.L.C.
878.17K
0.72%
+113.28K
+14.81%
Sep 30, 2025
Micallef (Jacob Vincent)
444.76K
0.36%
-5.85K
-1.30%
Oct 04, 2025
BlackRock Institutional Trust Company, N.A.
445.19K
0.36%
--
--
Sep 30, 2025
더 보기
관련 ETF
마지막 업데이트: Sat, Dec 6
마지막 업데이트: Sat, Dec 6
이름
비율
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
비율0%
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
배당락일
유형
비율
데이터 없음
날짜
배당락일
유형
비율
데이터 없음
